Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review

BACKGROUND: A precision medicine approach in type 2 diabetes requires the identification of clinical and biological features that are reproducibly associated with differences in clinical outcomes with specific anti-hyperglycaemic therapies. Robust evidence of such treatment effect heterogeneity coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Katherine G., McInnes, Eram Haider, Massey, Robert J., Kahkoska, Anna R., Pilla, Scott J., Raghavan, Sridharan, Stanislawski, Maggie A., Tobias, Deirdre K., McGovern, Andrew P., Dawed, Adem Y., Jones, Angus G., Pearson, Ewan R., Dennis, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551026/
https://www.ncbi.nlm.nih.gov/pubmed/37794166
http://dx.doi.org/10.1038/s43856-023-00359-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551026/
https://www.ncbi.nlm.nih.gov/pubmed/37794166
http://dx.doi.org/10.1038/s43856-023-00359-w

Ejemplares similares